Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

SY0916

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

KetonesPiperidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Degradation Characteristics of a Novel PAF Receptor Antagonist, SY0916, in Aqueous Solution
SY0916 has been proven to be a potent treatment agent against rheumatoid arthritis in preclinical studies and has been shown to… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
2016
2016
The antinociceptive effect and mechanism of action of SY0916.
2014
2014
The inhibition effect and mechanism of SY0916 on pulmonary fibrosis
SY0916 is a new platelet-activating factor receptor antagonist developed by our institute. In this study, the inhibitory effect… 
2011
2011
Inhibitory effects of SY0916, a platelet-activating factor receptor antagonist, on the angiogenesis of human umbilical vascular endothelial cells
SY0916 is a novel platelet-activating factor receptor antagonist. The objective of this study is to explore the anti-angiogenesis… 
2011
2011
Anti-Angiogenesis Effects of Platelet Activating Factor Receptor Antagonist SY0916 on Macrophage
OBJECTIVE To investigate the in vitro anti-angiogenesis effect of platelet activating factor(PAF)receptor antagonist SY0916 on… 
2010
2010
Effects and mechanism of aromatic aminoketone SY0916 on osteoclastic bone destruction
AbstractAim:To study the effects and mechanism of aromatic aminoketone (SY0916) on bone destruction in vitro.Methods:MC3T3-E1… 
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE